Literature DB >> 3709626

Verapamil and breast-feeding.

M R Miller, R Withers, R Bhamra, D W Holt.   

Abstract

Concentrations of verapamil and norverapamil were measured in the plasma and breast milk of a woman receiving 120 mg verapamil three times daily. Whilst the concentrations of verapamil in breast milk averaged about 64% of those in maternal plasma no drug could be detected in the plasma of the infant. It is concluded that maternal therapy with verapamil does not pose a hazard to the suckling infant.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3709626     DOI: 10.1007/bf00614209

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  6 in total

1.  Level of verapamil in human milk.

Authors:  H Inoue; N Unno; M C Ou; Y Iwama; T Sugimoto
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

2.  Changing composition of human milk and early development of an appetite control.

Authors:  B Hall
Journal:  Lancet       Date:  1975-04-05       Impact factor: 79.321

3.  Rapid high-performance liquid chromatographic method for the measurement of verapamil and norverapamil in blood plasma or serum.

Authors:  S C Cole; R J Flanagan; A Johnston; D W Holt
Journal:  J Chromatogr       Date:  1981-11-20

4.  Systemic availability of oral verapamil and effect on PR interval in man.

Authors:  A Johnston; C D Burgess; J Hamer
Journal:  Br J Clin Pharmacol       Date:  1981-09       Impact factor: 4.335

5.  Pharmacokinetics, bioavailability and ECG response of verapamil in patients with liver cirrhosis.

Authors:  A Somogyi; M Albrecht; G Kliems; K Schäfer; M Eichelbaum
Journal:  Br J Clin Pharmacol       Date:  1981-07       Impact factor: 4.335

6.  Excretion of verapamil in human milk.

Authors:  H J Andersen
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

  6 in total
  9 in total

1.  Nifedipine is excreted in human milk.

Authors:  W J Penny; M J Lewis
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

2.  Excretion of tiapamil in breast milk.

Authors:  D Hartmann; N O Lunell; G Friedrich; A Rane
Journal:  Br J Clin Pharmacol       Date:  1988-08       Impact factor: 4.335

Review 3.  Management of tachyarrhythmias in pregnancy - A review.

Authors:  Priyanka Kugamoorthy; Danna A Spears
Journal:  Obstet Med       Date:  2020-04-20

Review 4.  Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  D McTavish; E M Sorkin
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

Review 5.  Cluster Headache: Special Considerations for Treatment of Female Patients of Reproductive Age and Pediatric Patients.

Authors:  Juliana VanderPluym
Journal:  Curr Neurol Neurosci Rep       Date:  2016-01       Impact factor: 5.081

6.  Verapamil and norverapamil in plasma and breast milk during breast feeding.

Authors:  P Anderson; U Bondesson; I Mattiasson; B W Johansson
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 7.  The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation.

Authors:  G M Mitani; I Steinberg; E J Lien; E C Harrison; U Elkayam
Journal:  Clin Pharmacokinet       Date:  1987-04       Impact factor: 6.447

Review 8.  Drugs in human milk. Clinical pharmacokinetic considerations.

Authors:  H C Atkinson; E J Begg; B A Darlow
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

Review 9.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.